In addition, we found more people with 14167C polymorphisms in the control group than in the AMD patient group, but the difference was not significant when adjusted for age, sex, smoking status, and CFH and ARMS2 status (OR=0.7 [0.4–1.1], p=0.09 for C versus T allele bearers). This evidence concerns the gene ARMS2 and age-related macular degeneration.